Terapie
komórkami macierzystymi
Terapie komórkami macierzystymi
Celem bankowania komórek macierzystych jest ich późniejsze wykorzystanie w terapii. Krew pępowinowa została zastosowana po raz pierwszy w 1988 roku, a od tego czasu – zgodnie z dostępnymi danymi – komórki macierzyste zostały użyte na świecie ponad 85 000 razy (łącznie ze statystykami z Chin).
Grupa FamiCord przechowuje ponad 1 000 000 porcji komórek różnych typów i dostarczyła komórki macierzyste do zastosowań klinicznych dla ponad 7000 pacjentów. Dostarczamy komórki do standardowych przeszczepień (z krwi pępowinowej, szpiku kostnego i mobilizowanej krwi obwodowej) oraz do terapii komórkowych. Ponadto wytwarzamy produkty komórkowe w standardzie GMP (ang. Good Manufacturing Practice) do badań klinicznych.
Komórki macierzyste pochodzące z naszych laboratoriów były wykorzystywane w leczeniu pacjentów z chorobami i wskazaniami z różnych obszarów terapeutycznych – m.in. hematologii, neurologii, okulistyki, ortopedii i dermatologii.
Sprawdź pełną listę pacjentów, którzy otrzymali terapię komórkami macierzystymi pochodzącymi z laboratoriów Grupy FamiCord.
Data aktualizacji: 06.2026
Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord
| Lp. | Źródło | Typ źródła | Wskazanie | Obszar medycyny | Rok podania | Terapia | Kraj | Wiek odbiorcy |
|---|---|---|---|---|---|---|---|---|
| 5101 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 5102 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 16 |
| 5103 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 42 |
| 5104 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Metabolic | 2019 | Standard Therapy | Poland | 3 |
| 5105 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 18 |
| 5106 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 8 |
| 5107 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 10 |
| 5108 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 25 |
| 5109 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 30 |
| 5110 | Bone Marrow | Allogeneic | C-Hip Cartilage-Hair Hypoplasia | Orthopedics | 2019 | Standard Therapy | Poland | 2 |
| 5111 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 7 |
| 5112 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 9 |
| 5113 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 35 |
| 5114 | Bone Marrow | Allogeneic | Congenital Amegakaryocytic Thrombocytopenia (Camt) | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 5115 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 5116 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2019 | Standard Therapy | Poland | 6 |
| 5117 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 5118 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 5119 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 5120 | Bone Marrow | Allogeneic | Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 5121 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type I | Metabolic | 2019 | Standard Therapy | Poland | 2 |
| 5122 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 75 |
| 5123 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 57 |
| 5124 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 5125 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 8 |
| 5126 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 5127 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 75 |
| 5128 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 5129 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 27 |
| 5130 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 5131 | Bone Marrow | Allogeneic | Myeloproliferative Syndrome | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 5132 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2019 | Standard Therapy | Poland | 6 |
| 5133 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2019 | Standard Therapy | Poland | 16 |
| 5134 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 5135 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 5136 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 5137 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 64 |
| 5138 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 43 |
| 5139 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 5140 | Bone Marrow | Allogeneic | Ohis – Other Histiocytic Disorders | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 5141 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2019 | Standard Therapy | Poland | 1 |
| 5142 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2019 | Standard Therapy | Poland | 5 |
| 5143 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 5144 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 5145 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 22 |
| 5146 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
| 5147 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 12 |
| 5148 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 5149 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 17 |
| 5150 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 4 |
| 5151 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 22 |
| 5152 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
| 5153 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 5154 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 5155 | Bone Marrow | Allogeneic | Shwachman Diamond Anemia | Hematology | 2019 | Standard Therapy | Poland | 20 |
| 5156 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 13 |
| 5157 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 5158 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 10 |
| 5159 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 13 |
| 5160 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 4 |
| 5161 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 27 |
| 5162 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 47 |
| 5163 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 5164 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 5165 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 5166 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 18 |
| 5167 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 20 |
| 5168 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 15 |
| 5169 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 43 |
| 5170 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 51 |
| 5171 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 7 |
| 5172 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 5173 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 46 |
| 5174 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 48 |
| 5175 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 5176 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 28 |
| 5177 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 36 |
| 5178 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 36 |
| 5179 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 5180 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 43 |
| 5181 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 32 |
| 5182 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 44 |
| 5183 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 5184 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 5185 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 39 |
| 5186 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 53 |
| 5187 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 5188 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 5189 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 37 |
| 5190 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
| 5191 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 36 |
| 5192 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 53 |
| 5193 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 57 |
| 5194 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 38 |
| 5195 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 5196 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 5197 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
| 5198 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 70 |
| 5199 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 5200 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |